AtriCure, Inc.

ATRC Healthcare Medical Instruments & Supplies

AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 12.8%, EPS grew 238.5%, free cash flow fell 2.79% and total debt fell 4.43%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

56.09 1.69 −2.92%
Market cap
$2.9B
P/E
259×
Fwd P/E
591×
Dividend yield
—
F-score
7/9
Altman Z
7.31
Beneish M
−2.91
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 62.64 0.00 0.00 0.00 0.00 0.00
Piotroski F-Score
7 4 6 3 4 4 2 5 4 4
P/S ratio
3.53 3.08 4.10 6.21 11.42 11.35 5.29 5.17 3.42 3.91
Altman Z-Score
7.31 5.81 6.78 9.33 14.67 4.53 2.07 5.72 2.72 2.87
P/FCF ratio
103.31 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
3.44 2.76 3.17 3.18 4.47 1.87 (0.12) 2.33 (0.56) (0.12)
Beneish M-Score
(2.91) (2.80) (2.60) (2.24) (1.75) (2.85) (2.28) (2.70) (2.73) (2.88)
P/Operating CF
94.32 245.93 405.86 44,586.56 10,410.10 593.10 (346.28) 1,058.95 391.48 797.49
P/B ratio
3.84 3.11 3.51 4.49 6.48 5.69 4.94 4.18 3.71 3.60
Price to Tangible BV
9.03 8.46 9.77 11.23 15.21 47.46 0.00 10.99 116.27 54.90
EV/Sales
3.40 3.00 3.96 6.06 11.25 10.49 5.26 4.81 3.45 3.89
EV/EBITDA
157.03 0.00 0.00 0.00 20.41 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
31.67 114.31 352.28 (90.39) (223.94) (109.07) (76.77) (232.30) (67.43) (39.86)
EV/FCF
99.30 (47.73) (42.11) (51.29) (131.13) (86.24) (43.42) (93.38) (39.35) (26.42)
Quick Ratio
2.87 2.49 2.55 2.81 2.69 5.44 2.20 3.72 1.80 2.26
Current Ratio
3.96 3.65 3.57 3.69 3.47 6.24 2.87 4.34 2.58 2.97
Net Debt/EBITDA
(9.13) 2.94 7.13 1.71 (0.31) 5.41 0.34 8.75 (0.19) 0.24
Debt/Assets
9.46% 10.15% 9.87% 12.20% 11.63% 9.26% 13.20% 14.70% 13.98% 14.07%
Debt/Equity
0.13 0.13 0.13 0.16 0.15 0.16 0.30 0.21 0.23 0.23
Asset Turnover
0.85 0.76 0.67 0.55 0.41 0.32 0.50 0.65 0.64 0.56
Operating CF/Net income
(5.01) (0.27) (0.15) 0.48 (0.27) 0.41 0.45 0.20 0.33 0.45
Capex/Depreciation
(0.43) (0.59) (0.75) (1.23) (0.10) (0.47) (1.38) (0.70) (0.68) (0.80)
Interest Coverage
(1.61) (6.25) (3.85) (8.56) 11.23 (9.05) (8.06) (3.72) (11.03) (17.29)
ROE
(2.40%) (9.64%) (6.60%) (9.88%) 11.20% (14.60%) (14.17%) (10.30%) (16.32%) (18.78%)
ROA
(1.81%) (7.31%) (5.08%) (7.74%) 7.55% (7.57%) (7.70%) (6.77%) (9.88%) (12.13%)
ROIC
(1.53%) (6.25%) (4.28%) (6.55%) 7.91% (11.80%) (8.66%) (6.03%) (9.51%) (11.92%)
Return on Tangible Assets
(4.09%) (18.93%) (13.00%) (23.75%) 29.35% (16.84%) (27.96%) (13.08%) (34.00%) (38.37%)
Average Days of Receivables
45.51 47.33 48.00 47.17 43.94 40.91 44.35 45.61 48.22 49.64
Research and Development Expense of Revenue
18.56% 20.67% 18.51% 17.35% 17.68% 20.85% 17.86% 17.22% 19.54% 23.10%
Selling, General and Administrative Expense of Revenue
58.19% 62.62% 63.40% 70.00% 74.60% 73.03% 72.42% 64.24% 66.96% 68.61%
Intangible Assets out of Total Assets
0.43 0.48 0.49 0.47 0.45 0.51 0.65 0.43 0.58 0.57
Share Based Compensation of Revenue
8.36% 8.68% 8.95% 8.71% 10.24% 10.96% 7.79% 8.18% 8.37% 7.54%
Graham Net Nets
0.08 0.08 0.07 0.04 0.02 0.00 (0.14) 0.06 (0.04) (0.04)
Graham Number
0.00 0.00 0.00 0.00 16.37 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(0.60%) (3.11%) (1.87%) (2.25%) 1.60% (2.07%) (2.86%) (2.06%) (4.49%) (5.47%)
Free Cash Flow Yield
0.97% (2.04%) (2.29%) (1.90%) (0.75%) (1.07%) (2.29%) (0.99%) (2.56%) (3.76%)
Revenue per Share
11.19 9.91 8.62 7.22 6.09 4.90 6.14 5.92 5.39 4.91
Operating CF per Share
1.20 0.26 0.10 (0.48) (0.31) (0.47) (0.42) (0.12) (0.28) (0.48)
Capex per Share
(0.19) (0.24) (0.26) (0.37) (0.22) (0.12) (0.32) (0.18) (0.20) (0.24)
Free Cash Flow per Share
1.01 0.02 (0.16) (0.85) (0.52) (0.60) (0.74) (0.30) (0.47) (0.72)
Cash per Share
3.51 2.61 2.96 2.65 2.64 5.80 2.18 3.65 1.06 1.39
Shareholders Equity per Share
10.30 9.82 10.07 9.99 10.73 9.79 6.58 7.32 4.98 5.33
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
10.30 9.82 10.07 9.99 10.73 9.79 6.58 7.32 4.98 5.33
Free Cash Flow
48.28 0.77 (7.51) (39.02) (23.53) (25.13) (27.95) (10.38) (15.33) (22.81)
Working Capital
241.00 194.40 191.68 156.82 139.63 257.60 93.24 134.46 50.36 56.89
Capital Expenditures
(9.05) (11.43) (12.00) (16.88) (9.75) (5.26) (12.14) (6.20) (6.38) (7.69)
Net Current Asset Value
160.27 119.47 118.48 86.52 64.52 4.59 (167.38) 67.30 (24.28) (22.26)
EV/EBIT
0.00 0.00 0.00 0.00 55.90 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.02 0.02 0.03 0.05 0.04 0.03 0.05 0.03 0.04 0.05
Price to Operating Income
0.00 0.00 0.00 0.00 56.76 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.54 0.46 0.38 0.35 3.06 0.40 0.27 0.33 0.33 0.32
Cash ROIC
6.69% 0.12% (1.13%) (6.01%) (3.49%) (3.48%) (6.94%) (2.43%) (6.58%) (9.07%)
Accounts Receivable Turnover
8.42 8.25 8.39 8.73 9.77 8.07 8.67 8.35 7.91 7.66
Accounts Payable Turnover
5.31 4.50 4.19 4.39 4.37 4.13 4.92 4.94 4.20 3.76
Inventory Turnover
1.74 1.64 1.74 1.99 1.85 1.78 2.33 2.43 2.42 2.49
Average Days of Payables
69.07 77.57 100.98 86.01 99.14 81.24 90.22 64.68 93.45 88.52
Days of Inventory on Hand
214.20 233.46 250.64 198.54 207.71 223.42 177.54 150.55 168.78 146.47
Average Receivables
63.50 56.42 47.60 37.86 28.08 25.60 26.62 24.14 22.09 20.25
Average Payables
25.17 26.19 23.63 19.25 15.67 13.84 12.30 11.05 11.55 11.71
Average Inventory
76.91 71.62 56.91 42.45 37.00 32.22 25.95 22.47 20.06 17.66
Average Assets
631.75 611.63 599.69 600.38 664.93 636.21 457.32 312.23 272.06 274.76
Average Common Equity
476.45 463.57 461.46 470.26 448.08 329.87 248.36 205.27 164.80 177.56

Fold the line items

Columns are period end dates